Accordingly, the objective of this study was to investigate the diagnostic potential of miR-101 for HCV-HCC as an alternative biomarker for AFP by estimating fold-change expression levels among HCC and cirrhotic groups compared with control groups, ultimately improving diagnostic methods for the early detection and treatment of HCV-HCC. Here, AFP is linked to hepatocellular carcinoma.